We are live on ! Find out more
AAS

Ameritas Advisory Services Portfolio holdings

AUM $2.58B
1-Year Est. Return 18.84%
This Fund
S&P 500
This Quarter Est. Return
-0.9%
1 Year Est. Return
+18.84%
3 Year Est. Return
+55.33%
5 Year Est. Return
10 Year Est. Return
AUM
$2.58B
AUM Growth
-$101M
Cap. Flow
-$53.6M
Cap. Flow %
-2.08%
Top 10 Hldgs %
17.62%
Holding
1,138
New
212
Increased
324
Reduced
492
Closed
63

Sector Composition

Rank Sector Weight
1 Technology 8.11%
2 Financials 3.16%
3 Industrials 2.33%
4 Consumer Discretionary 2.26%
5 Communication Services 2.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GFS icon
1051
GlobalFoundries
GFS
$29.4B
$133 ﹤0.01%
+3
New +$132
MOH icon
1052
Molina Healthcare
MOH
$10.3B
$133 ﹤0.01%
+1
New +$159
SKWD icon
1053
Skyward Specialty Insurance
SKWD
$2.45B
$131 ﹤0.01%
+3
New +$136
SMPL icon
1054
Simply Good Foods
SMPL
$904M
$129 ﹤0.01%
+9
New +$155
PVLA
1055
Palvella Therapeutics
PVLA
$1.98B
$125 ﹤0.01%
+1
New +$104
ZBIO
1056
Zenas BioPharma
ZBIO
$1.92B
$117 ﹤0.01%
+6
New +$135
XPEV icon
1057
XPeng
XPEV
$11.8B
$86 ﹤0.01%
+5
New +$93
MUR icon
1058
Murphy Oil
MUR
$5.58B
$83 ﹤0.01%
+2
New +$68
TAL icon
1059
TAL Education Group
TAL
$5.71B
$80 ﹤0.01%
+7
New +$79
DAO
1060
Youdao
DAO
$1.85B
$69 ﹤0.01%
+7
New +$73
AVPT icon
1061
AvePoint
AVPT
$2.6B
$67 ﹤0.01%
+7
New +$79
MNSO icon
1062
MINISO
MNSO
$3.64B
$65 ﹤0.01%
+4
New +$73
FINV
1063
FinVolution Group
FINV
$1.12B
$57 ﹤0.01%
+12
New +$64
LI icon
1064
Li Auto
LI
$12.6B
$53 ﹤0.01%
+3
New +$52
COCO icon
1065
Vita Coco
COCO
$3.77B
$48 ﹤0.01%
+1
New +$55
PCRX icon
1066
Pacira BioSciences
PCRX
$1.02B
$45 ﹤0.01%
+2
New +$44
AMLX icon
1067
Amylyx Pharmaceuticals
AMLX
$2.05B
$42 ﹤0.01%
+3
New +$42
CAPR icon
1068
Capricor Therapeutics
CAPR
$1.14B
$30 ﹤0.01%
+1
New +$27
ARLO icon
1069
Arlo Technologies
ARLO
$1.4B
$28 ﹤0.01%
+2
New +$27
CRK icon
1070
Comstock Resources
CRK
$3.97B
$21 ﹤0.01%
+1
New +$21
PLGO
1071
Pelagos Insurance Capital
PLGO
$2.19B
$19 ﹤0.01%
+1
New +$19
SMMT icon
1072
Summit Therapeutics
SMMT
$10.9B
$19 ﹤0.01%
+1
New +$16
REPL icon
1073
Replimune Group
REPL
$814M
$15 ﹤0.01%
+2
New +$15
ADMA icon
1074
ADMA Biologics
ADMA
$1.92B
$9 ﹤0.01%
+1
New +$16
TSHA icon
1075
Taysha Gene Therapies
TSHA
$1.59B
$4 ﹤0.01%
+1
New +$5

Similar funds

Ameritas Advisory Services's Q1 2026 Portfolio in Review

As of Q1 2026, Ameritas Advisory Services held 1,138 positions worth $2.58B, down 3.8% from $2.68B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Ameritas Advisory Services's Q1 2026 filing shows 212 new, 324 increased, 492 reduced and 63 closed positions. Its largest new stake was State Street SPDR Bloomberg Investment Grade Floating Rate ETF: 287,517 shares worth $8.85M. The largest sale was Invesco QQQ Trust, an estimated $14.6M.

By sector, the portfolio is most concentrated in Technology at 8.1% of assets, down from 8.7% a quarter earlier, followed by Financials and Industrials.

  • Ameritas Advisory Services's largest Q1 2026 buy was State Street SPDR Bloomberg Investment Grade Floating Rate ETF: 287,517 shares worth $8.85M.
  • Ameritas Advisory Services added most to Columbia Research Enhanced Core ETF in Q1 2026, an estimated $10.6M increase.
  • Ameritas Advisory Services's biggest Q1 2026 reduction was Invesco QQQ Trust, cutting an estimated $14.6M.
  • Ameritas Advisory Services fully exited Invesco Short Term Treasury ETF in Q1 2026, selling an estimated $2.97M.
  • Ameritas Advisory Services's ten largest holdings make up 18% of its $2.58B portfolio in Q1 2026.
  • Ameritas Advisory Services opened 212 new positions and closed 63 in Q1 2026.
  • Ameritas Advisory Services's portfolio value fell 3.8% quarter-over-quarter to $2.58B.

Based on Ameritas Advisory Services's 13F filing for Q1 2026, filed 12 May 2026.